Lido Advisors
GILD icon

Lido Advisors’s Gilead Sciences GILD Stock Holding History

Lido Advisors’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-3,300
Closed -$405K – 2019
2025
Q4 		$405K Hold
3,300
– – ﹤0.01% 1394
2025
Q3 		$366K Hold
3,300
– – ﹤0.01% 1391
2025
Q2 		$366K Buy
+3,300
New +$351K ﹤0.01% 1247

Other funds holding GILD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Lido Advisors's GILD Position: Q1 2026 in Review

Lido Advisors reduced its Gilead Sciences (GILD) stake by 2.2% in Q1 2026, selling an estimated $388K and leaving 120,592 shares worth $16.8M. The position accounts for 0.05% of the portfolio, ranked #229.

Lido Advisors first reported a position in GILD in Q1 2016 and has held it in 38 quarters since. 2,309 funds tracked by Wall St. Rank hold GILD as of Q1 2026.

  • Lido Advisors held 120,592 shares of Gilead Sciences worth $16.8M as of Q1 2026.
  • Lido Advisors sold 2,772 Gilead Sciences shares in Q1 2026, an estimated $388K.
  • Gilead Sciences made up 0.05% of Lido Advisors's portfolio in Q1 2026, its #229 holding.
  • Lido Advisors first reported a position in Gilead Sciences in Q1 2016 and has held it in 38 quarters since.
  • 2,309 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.

Based on Lido Advisors's 13F filing for Q1 2026, filed 13 May 2026.